One Drop Launches Global Commercial Partnership with Bayer

Vinson & Elkins advised One Drop, a leader in the development of digital therapeutic solutions for diabetes and other chronic conditions, in connection with a $40 million Series B financing, led by Bayer, one of the largest pharmaceutical companies in the world.

Bayer has also entered a commercial licensing agreement to use One Drop’s platform in Bayer’s global bio-digital efforts in therapeutic areas such as oncology, cardiovascular disease and women’s health.

The V&E corporate team was led by partner Paul Tobias and counsel Andy Smetana with assistance from associates Ben Cukerbaum and Vaughn Miller. Also advising was partner Damara Chambers.

For more information, please speak with our media contacts.

Key Contacts

Partner

Paul R. Tobias

+1.512.542.8450

ptobias@velaw.com

Related Insights

Event Recap

ESG Symposium: Capital, Climate and Culture in the New World

Tuesday, September 15, 2020
Video
Event

The Future of Cleantech Innovation and Investments in Renewable Energy

Friday, September 11, 2020
V&E⁺

3 Things to Know About President Trump’s Bulk-Power System Order

August 14, 2020
V&E⁺

Pioneering a Solution for Debt Holders During a Pandemic

August 10, 2020